Figure 2 shows the role of Blimp-1 across different immune cell types, illustrating its impact on ROS modulation and inflammation control, with therapeutic implications for metabolic diseases like diabetes and atherosclerosis. This evidence concerns the gene PRDM1 and diabetes mellitus.